Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Pfizer Inc

Market Cap 149B 129B 119B 111B 209B 14,199B 212B 1,404B 547B 6,911B 561B 549B 23,930B P/E Ratio 2026 *
12.3x
P/E Ratio 2027 * 13x
Enterprise Value 198B 171B 157B 147B 276B 18,788B 280B 1,858B 724B 9,145B 742B 726B 31,663B EV / Sales 2026 *
3.2x
EV / Sales 2027 * 3.23x
Free-Float
59.05%
Yield 2026 *
6.68%
Yield 2027 * 6.66%
Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 61 2022-05-01
Chief Tech/Sci/R&D Officer - 2006-12-31
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.41%+0.14%+39.53%+154.43% 1,010B
+1.07%+3.48%+53.75%+50.64% 580B
+1.32%+0.22%+18.35%+65.35% 402B
+0.77%0.00%+19.99%+16.80% 330B
-1.42%-1.44%+45.50%+8.37% 294B
-0.85%-2.86%+22.05%+13.80% 280B
+0.44%+3.48%+24.48%+34.39% 281B
+1.66%+1.20%-44.67%-47.49% 197B
+0.32%+1.61%+19.48%+63.42% 192B
Average -0.28%+0.99%+22.05%+39.97% 396.34B
Weighted average by Cap. -0.80%+1.00%+29.84%+66.16%

Financials

2026 *2027 *
Net sales 61.69B 53.28B 49.1B 45.96B 86.13B 5,864B 87.46B 580B 226B 2,854B 232B 227B 9,882B 59.32B 51.24B 47.22B 44.2B 82.83B 5,639B 84.11B 558B 217B 2,745B 223B 218B 9,503B
Net income 11.07B 9.56B 8.81B 8.25B 15.46B 1,052B 15.7B 104B 40.56B 512B 41.55B 40.66B 1,773B 10.96B 9.47B 8.72B 8.17B 15.3B 1,042B 15.54B 103B 40.16B 507B 41.13B 40.26B 1,756B
Net Debt 48.28B 41.7B 38.42B 35.97B 67.4B 4,589B 68.45B 454B 177B 2,234B 181B 177B 7,733B 42.08B 36.34B 33.49B 31.35B 58.75B 3,999B 59.66B 395B 154B 1,947B 158B 155B 6,740B
Logo Pfizer Inc
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!